Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 0 | 3,570,206 | +3,570,206 | $0 | $156.73M | 12.39% | +$156.73M |
| Dyne Therapeutics, Inc.COMM(DYN) | 1,650,150 | 2,650,150 | +1,000,000 | $21.95M | $75.24M | 5.95% | +$53.29M |
| Astria Therapeutics, Inc.COMM | 0 | 5,278,928 | +5,278,928 | $0 | $74.30M | 5.87% | +$74.30M |
| Silence Therapeutics plcADRS(SLN) | 2,104,875 | 3,295,350 | +1,190,475 | $36.56M | $71.18M | 5.63% | +$34.62M |
| Structure Therapeutics IncADRS | 2,109,584 | 1,598,421 | -511,163 | $85.99M | $68.51M | 5.42% | -$17.48M |
| Aerovate Therapeutics IncCOMM | 2,201,274 | 2,201,274 | 0 | $49.81M | $65.09M | 5.15% | +$15.28M |
| Inhibrx,incCOMM | 1,750,387 | 1,750,387 | 0 | $66.51M | $61.19M | 4.84% | -$5.32M |
| Keros Therapeutics, Inc.COMM(KROS) | 0 | 879,344 | +879,344 | $0 | $58.21M | 4.60% | +$58.21M |
| Geron CorporationCOMM(GERN) | 23,375,839 | 17,391,639 | -5,984,200 | $49.32M | $57.39M | 4.54% | +$8.07M |
| Savara Inc.COMM(SVRA) | 10,000,000 | 10,000,000 | 0 | $47.00M | $49.80M | 3.94% | +$2.80M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 0 | 5,319,148 | +5,319,148 | $0 | $48.40M | 3.83% | +$48.40M |
| Cogent Biosciences, Inc.COMM(COGT) | 5,631,042 | 6,214,375 | +583,333 | $33.11M | $41.76M | 3.30% | +$8.65M |
| Edgewise Therapeutics, Inc.COMM(EWTX) | 0 | 2,272,728 | +2,272,728 | $0 | $41.45M | 3.28% | +$41.45M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 0 | 3,185,185 | +3,185,185 | $0 | $41.12M | 3.25% | +$41.12M |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 179,917 | 149,283 | -30,634 | $41.63M | $39.86M | 3.15% | -$1.76M |
| Tourmaline Bio IncCOMM | 1,007,902 | 1,477,593 | +469,691 | $26.39M | $33.84M | 2.68% | +$7.45M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 1,989,103 | 0 | $27.55M | $32.62M | 2.58% | +$5.07M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $33.76M | $32.10M | 2.54% | -$1.66M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $20.47M | $30.37M | 2.40% | +$9.89M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 1,142,857 | 793,829 | -349,028 | $23.14M | $28.86M | 2.28% | +$5.71M |
| Adverum Biotechnologies, Inc.COMM | 0 | 2,008,340 | +2,008,340 | $0 | $28.40M | 2.25% | +$28.40M |
| Soleno Therapeutivs, Inc.COMM | 0 | 550,000 | +550,000 | $0 | $23.54M | 1.86% | +$23.54M |
| Centessa Pharmaceuticals PlcCOMM | 2,040,816 | 2,040,816 | 0 | $16.24M | $23.06M | 1.82% | +$6.82M |
| ABIVAX Société AnonymeADRS(ABVX) | 1,100,000 | 1,100,000 | 0 | $11.77M | $15.73M | 1.24% | +$3.96M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $13.76M | $14.13M | 1.12% | +$374.7K |
| Kalvista Pharmaceuticals, IncCOMM | 3,395,495 | 1,163,356 | -2,232,139 | $41.59M | $13.80M | 1.09% | -$27.80M |
| C4 Therapeutics, Inc.COMM(CCCC) | 1,276,574 | 1,276,574 | 0 | $7.21M | $10.43M | 0.82% | +$3.22M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $8.83M | $8.29M | 0.66% | -$538.2K |
| AN2 Therapeutics, Inc.COMM | 2,678,209 | 1,555,118 | -1,123,091 | $54.88M | $5.05M | 0.40% | -$49.82M |
| Kodiak Sciences Inc.COMM(KOD) | 267,941 | 899,999 | +632,058 | $814.5K | $4.73M | 0.37% | +$3.92M |
| Ventyx Biosciences, IncCOMM | 815,724 | 815,724 | 0 | $2.01M | $4.49M | 0.35% | +$2.47M |
| Nektar TherapeuticsCOMM(NKTR) | 0 | 4,000,000 | +4,000,000 | $0 | $3.74M | 0.30% | +$3.74M |
| Cabaletta Bio, Inc.COMM(CABA) | 486,795 | 86,795 | -400,000 | $11.05M | $1.48M | 0.12% | -$9.57M |
| Gracell Biotechnologies Inc.ADRS | 4,514,786 | 0 | -4,514,786 | $45.33M | $0 | — | -$45.33M |
| Icosavax IncCOMM | 3,703,704 | 0 | -3,703,704 | $58.37M | $0 | — | -$58.37M |
| Nurix Therapeutics, Inc.COMM(NRIX) | 717,654 | 0 | -717,654 | $7.41M | $0 | — | -$7.41M |
| Rayzebio, Inc.COMM | 869,908 | 0 | -869,908 | $54.08M | $0 | — | -$54.08M |
| Taysha Gene Therapies, Inc.COMM(TSHA) | 2,912,861 | 0 | -2,912,861 | $5.16M | $0 | — | -$5.16M |